Precision Genomic Integration for High-Performance Industrial Strains. Aspergillus niger is widely regarded as one of the most efficient eukaryotic hosts for the secretion of proteins and organic acids. However, traditional random integration often leads to unpredictable expression levels and genetic instability. CD Biosynsis provides professional Aspergillus niger Gene Knock-in Services, utilizing advanced CRISPR-Cas9-mediated Homology-Directed Repair (HDR) and site-specific recombinase platforms. Our service enables the precise insertion of exogenous or endogenous genes into "safe harbor" loci or high-transcription regions to ensure stable, high-yield, and scalable production.
Get a Technical QuoteOur gene knock-in platform is engineered to support complex genomic rewiring in filamentous fungi, covering pharmaceutical, energy, and food industries. We focus on achieving high-level secretion of complex proteins through targeted genomic positioning.
| Service Tier | Technical Focus | Primary Application | Strategic Value |
|---|---|---|---|
| Multi-Copy Integration | High-efficiency iterative knock-in | Therapeutic protein production | Maximizes total secretion titers |
| Site-Specific Targeted KI | Precise HDR-mediated insertion | Stable enzyme & acid production | Avoids position effects & instability |
| Heterologous Expression | Fungal-optimized codon integration | Biofuel & Biorefinery research | Enables biomass degradation pathways |
| Chaperone Co-expression | Synergistic multi-gene knock-in | High-yield industrial enzymes | Enhances folding & secretion efficiency |
| Promoter Swapping & KI | Strong/Inducible promoter integration | Dynamic metabolic control | Achieves temporal control of expression |
1. Genomic Mapping
2. Donor Construction
3. Advanced Delivery
4. Performance Characterization
Bioinformatic identification of optimal "Safe Harbor" or high-expression sites within the Aspergillus niger genome.
Technical project feasibility study and Mutual NDA signing.
Designing donor DNA with precise homology arms and optimized cassettes, including fungal promoters and signal peptides.
Verification of sequence accuracy and expression cassette functionality.
Introduction of the knock-in machinery via protoplast-mediated transformation or biolistic delivery optimized for filamentous fungi.
Strict aseptic processing to ensure high-fidelity genomic integration.
High-throughput screening followed by genotyping and evaluation of secretion levels in pilot-scale bioreactors.
Final delivery of engineered strains and comprehensive validation characterization dossiers.
We benchmark our precision genomic integration against landmark research to deliver superior industrial strains.
Producing human proteins in A. niger offers a scalable medical platform. Technical benchmarks utilized a Multi-Copy Gene Knock-in strategy to integrate human Pepsinogen A into multiple loci. Fermentation data demonstrated that this strategy significantly increased secretion levels over time, providing a robust route for therapeutic enzyme production.
(Reference: Fermentation, 2023)
Efficient xylan degradation is critical for second-generation biofuels. Utilizing CRISPR/Cas9-mediated Targeted Knock-in, researchers integrated endo-xylanase genes (eglA) from Aspergillus fumigatus into the host genome. The mutants exhibited enhanced activity and genetic stability, facilitating the development of high-performance lignocellulose-degrading strains.
(Reference: Nature Communications, 2023)
Industrial enzymes like Glucose Oxidase (GOD) often face cost bottlenecks. By precisely integrating and molecularly modifying the GOD gene, technical teams improved catalytic efficiency. Strategic co-expression of folding chaperones drastically increased secretion levels, providing a cost-effective route for industrial mass-production.
(Reference: Food Chemistry, 2024)
Ready to engineer a high-performance cell factory for your target molecule?
Contact Us1. How many copies of a gene can you knock in for high production?
While 1-3 copies are standard for stability, we can utilize iterative knock-in strategies or specific high-expression loci to achieve higher copy numbers if maximum yield is required.
2. Can you integrate genes from human or non-fungal sources?
Yes. We have extensive experience in the heterologous expression of human, bacterial, and plant genes. We perform extensive codon optimization to ensure perfect compatibility with the Aspergillus niger translational machinery.
3. What is the typical turnaround for a Gene Knock-in project?
A typical project, from design to validated homokaryotic strain, takes approximately 10-14 weeks depending on the number of genes and integration complexity.
4. Do you provide pilot-scale fermentation data for the engineered strain?
Yes. As part of our validation, we can test the engineered strain in our bioreactors to provide initial data on protein yield, secretion kinetics, and genetic stability.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.